Delineation of a new fibrillin-2-opathy with evidence for a role of


Journal

Journal of medical genetics
ISSN: 1468-6244
Titre abrégé: J Med Genet
Pays: England
ID NLM: 2985087R

Informations de publication

Date de publication:
11 2021
Historique:
received: 14 04 2020
revised: 08 07 2020
accepted: 26 07 2020
pubmed: 10 9 2020
medline: 22 2 2022
entrez: 9 9 2020
Statut: ppublish

Résumé

Although carpal tunnel syndrome (CTS) is the most common form of peripheral entrapment neuropathy, its pathogenesis remains largely unknown. An estimated heritability index of 0.46 and an increased familial occurrence indicate that genetic factors must play a role in the pathogenesis. We report on a family in which CTS occurred in subsequent generations at an unusually young age. Additional clinical features included brachydactyly and short Achilles tendons resulting in toe walking in childhood. Using exome sequencing, we identified a heterozygous variant (c.5009T>G; p.Phe1670Cys) in the fibrillin-2 ( The identification of a novel

Sections du résumé

BACKGROUND
Although carpal tunnel syndrome (CTS) is the most common form of peripheral entrapment neuropathy, its pathogenesis remains largely unknown. An estimated heritability index of 0.46 and an increased familial occurrence indicate that genetic factors must play a role in the pathogenesis.
METHODS AND RESULTS
We report on a family in which CTS occurred in subsequent generations at an unusually young age. Additional clinical features included brachydactyly and short Achilles tendons resulting in toe walking in childhood. Using exome sequencing, we identified a heterozygous variant (c.5009T>G; p.Phe1670Cys) in the fibrillin-2 (
CONCLUSION
The identification of a novel

Identifiants

pubmed: 32900841
pii: jmedgenet-2020-107085
doi: 10.1136/jmedgenet-2020-107085
doi:

Substances chimiques

FBN2 protein, human 0
Fibrillin-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

778-782

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R008221/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Silke Peeters (S)

Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.

Arne Decramer (A)

Department of Orthopaedics and Traumatology, AZ Delta, Roeselare, Belgium.

Stuart Alan Cain (SA)

Division of Cell-Matrix Biology and Regenerative Medicine, Wellcome Centre for Cell-Matrix Research, The University of Manchester, Manchester, UK.

Peter Houpt (P)

Department of Plastic Surgery, Isala Clinic Zwolle, Zwolle, The Netherlands.

Frederik Verstreken (F)

Department of Orthopaedic Surgery, AZ Monica, Deurne, Belgium.

Jan Noyez (J)

Department of Orthopaedics and Traumatology, AZ Delta, Roeselare, Belgium.

Christophe Hermans (C)

Center for Oncological Research Antwerp (CORE), University of Antwerp, Edegem, Belgium.

Werner Jacobs (W)

Department of Forensic Medicine and Pathology, Antwerp University Hospital and University of Antwerp, Edegem, Belgium.

Martin Lammens (M)

Department of Pathological Anatomy, Antwerp University Hospital, Edegem, Belgium.

Erik Fransen (E)

Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.

Ajay Anand Kumar (AA)

Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.
Department of Paediatrics, Wellcome-MRC Cambridge Stem Cell Institute Cambridge, Cambridge University, Cambridge, UK.

Geert Vandeweyer (G)

Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.
Biomedical Informatics Research Network Antwerp (Biomina), University of Antwerp, Edegem, Belgium.

Bart Loeys (B)

Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.

Wim Van Hul (W)

Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.

Clair Baldock (C)

Division of Cell-Matrix Biology and Regenerative Medicine, Wellcome Centre for Cell-Matrix Research, The University of Manchester, Manchester, UK.

Eveline Boudin (E)

Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.

Geert Mortier (G)

Department of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium geert.mortier@uantwerpen.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH